{"iri":"https://folio.openlegalstandard.org/1b1KZdAgRbWxsNMPwu4yyQ","label":"Pharmaceutical Preparation Manufacturing","sub_class_of":["https://folio.openlegalstandard.org/D0mnTJCRQ0iGNX03-SnqlQ"],"parent_class_of":[],"is_defined_by":"https://www.naics.com/six-digit-naics/?code=325412","see_also":[],"comment":null,"deprecated":false,"preferred_label":null,"alternative_labels":[],"translations":{},"hidden_label":null,"definition":"This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.","examples":[],"notes":[],"history_note":null,"editorial_note":null,"in_scheme":null,"identifier":null,"description":null,"source":null,"country":null}